Tthe researchers in the Storm Chase study believe a Long-Acting AntiBody (LAAB) known as AZD7442, developed by AstraZeneca, may offer immediate and long-term protection to people who have been recently exposed to coronavirus

The new purchase is part of a US government deal to secure nearly 1 million doses of Lilly's bamlanivimab

India Stock Market Highlights Today: Global equities were mostly buoyed today encouraged by news on the development of coronavirus vaccines and more assurance for a transition of power in the US to President-elect Joe Biden

The Food and Drug Administration (FDA) granted emergency use authorization (EUA) to Eli Lilly & Co's bamlanivimab based on trial data

India Stock Market Highlights Today: Tata Steel, Bharti Airtel, HCL Tech, Asian Paints and Bajaj Auto were among the top laggards today. On the other hand, ONGC, followed by NTPC, PowerGrid, UltraTech Cement, ITC, HDFC Bank, ICICI Bank and HDFC were among the top gainers.

Donald Trump, who was admitted at Walter Reed National Military Medical centre on Friday, had received \"a single 8-gram dose\" of Regeneron's monoclonal antibody cocktail

India Stock Market Highlights Today: All Sensex components were in the red with M&M, Bajaj Finance, IndusInd Bank, Maruti, Axis Bank, Bajaj Finserv and ICICI Bank shedding up to 33%.

The CP therapy involves taking antibodies from the blood of a person who has recovered from COVID-19 and transfusing those into an active coronavirus patient to help kickstart the immune system to fight the infection

China has maintained ministerial contacts with the United States as well as governments of other countries that supported Australia's pandemic stance, including Japan, Germany and France

Almost 64% of Australia's 549 deaths from COVID-19 have occurred among residents of aged-care homes, mostly in Victoria

Soumya Swaminathan, WHO chief scientist, said only a few clinical trials of convalescent plasma have produced results, and the evidence, at least so far, has not been convincing enough to endorse it beyond use as an experimental therapy

Plasma therapy, though not a magic bullet, has spurred a global drive to treat novel coronavirus patients using the antibody-rich blood of patients, who have recovered from the infection. Invented in the 1890s to cure diphtheria, plasma therapy helped reduce fatalities during the 1918 Spanish flu pandemic. Doctors across the world are now using the same technique to treat moderately-ill Covid-19 patients. An India Today investigation has unearthed a growing black-market for the plasma, born out of the desperation of families willing to do anything to save their loved ones infected with COVID-19. Watch the video for more.Delhi gets first plasma bank: How to donate plasma; check out eligibility, procedure

Delhi gets plasma bank: CM Kejriwal urged people who recovered from coronavirus to come and donate plasma. He said till a vaccine is found, plasma therapy will help coronavirus patients

Maharashtra government intends to save lives of some 500 critical COVID-19 patients through project PLATINA, the world's largest convalescent plasma therapy trial-cum-project

On progress on treatment options for COVID-19, Cadila said it is working on a DNA vaccine to fight coronavirus, which is currently in the animal testing stage

Coronavirus vaccine update: Germany's CureVac AG has received approval from the government to conduct human trials. The coronavirus vaccine candidate would first be tested 168 health people according to the government

Sun Pharma share price gained up to 2.08% to Rs 489 against previous close of Rs 479.60 on BSE

While two such therapies have entered the human clinical trial phase, more are expected in the coming weeks

Relying on developing herd immunity to fight coronavirus is \"too large a risk\" for any nation and only timely interventions can contain the spread of deadly virus, says Shekhar Mande, Director General of CSIR

Researchers at Peking University believe it can take about six months before drug is ready for use; after the animal stage, planning for a clinical trial is going on in full swing